Cart
sales@molnova.com
Zomepirac Sodium
CAS No. 64092-48-4
Zomepirac Sodium( —— )
Catalog No. M15437 CAS No. 64092-48-4
Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 26 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZomepirac Sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionZomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.
-
DescriptionZomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE2
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number64092-48-4
-
Formula Weight313.71
-
Molecular FormulaC15H13ClNNaO3
-
Purity>98% (HPLC)
-
SolubilityWater: 0.026 mg/mL
-
SMILES[Na+].CN1C(CC([O-])=O)=CC(C)=C1C(=O)C1=CC=C(Cl)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hata AN, et al. Mol Pharmacol. 2005 Mar;67(3):640-7.
molnova catalog
related products
-
RS 25344 hydrochlori...
RS 25344 hydrochloride is a phosphodiesterase (PDE) 4 inhibitor.
-
PDE9-IN-(S)-C33
PDE9-IN-(S)-C33 is a potent and selective inhibitor of PDE9 (IC50 = 11 nM). PDE9-IN-(S)-C33 can be used for central nervous system diseases and diabetes research.
-
Gisadenafil
Gisadenafil is a selective inhibitor of phosphodiesterase 5 (PDE5) with an IC50 of 3.6 nM and prevents degradation of cGMP.
